1. Global Initiative for Asthma (GINA), National Heart Lung and Blood Institute, National Institutes of Health: GINA report. Global strategy for asthma management and prevention. Bethesda: National Institutes of Health; 2006.
2. Global Initiative for Obstructive Lung Disease (GOLD), National Heart Lung and Blood Institute, National Institutes of Health: GOLD report. Global strategy for diagnosis, management and prevention of COPD. Bethesda: National Institutes of Health; 2009.
3. Flume PA, O’Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B: Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007, 176: 957–969. 10.1164/rccm.200705-664OC
4. Heijerman H, Westerman E, Conway S, Touw D, Döring G, consensus working group: Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibros 2009, 8: 295–315. 10.1016/j.jcf.2009.04.005
5. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H: What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011, 37: 1308–1331. 10.1183/09031936.00166410